# The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) Study

> **NCT05402124** · PHASE2 · UNKNOWN · sponsor: **University of Calgary** · enrollment: 100 (estimated)

## Conditions studied

- Colorectal Cancer
- Colorectal Adenoma
- Colorectal Adenomatous Polyp

## Interventions

- **DRUG:** acetylsalicylic acid delayed release tablets, 81mg

## Key facts

- **NCT ID:** NCT05402124
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07
- **Primary completion:** 2023-03
- **Final completion:** 2023-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-06-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05402124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05402124, "The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05402124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*